v3.26.1
Stock Based Compensation (Tables)
6 Months Ended
Aug. 01, 2026
Share-Based Payment Arrangement [Abstract]  
Non-Cash Stock Compensation Expense

Non-cash stock compensation expense is as follows:

 

 

(in thousands)

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

August 1,

 

 

August 2,

 

 

August 1,

 

 

August 2,

 

Type of Non-Cash Stock Compensation

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Restricted stock unit grants (a)

 

$

15,871

 

 

$

14,137

 

 

$

28,968

 

 

$

25,108

 

Stock option grants (a)

 

 

2,660

 

 

 

4,122

 

 

 

6,302

 

 

 

9,023

 

Performance stock unit grants (a)

 

 

13,583

 

 

 

14,189

 

 

 

33,146

 

 

 

20,133

 

Total (b)

 

$

32,114

 

 

$

32,448

 

 

$

68,416

 

 

$

54,264

 

 

(a)
Included in the line item “Selling, general and administrative expenses” in the Company’s Condensed Consolidated Statements of Income.
(b)
The amounts presented in the table above exclude taxes. For the three and six month periods ended August 1, 2026, the tax benefit related to the Company’s non-cash stock compensation was approximately $5.7 million and $12.9 million, respectively. For the three and six month periods ended August 2, 2025, the tax benefit related to the Company’s non-cash stock compensation was approximately $5.9 million and $10.1 million, respectively.
Stock Option Transactions

Stock option transactions during the six month period ended August 1, 2026 are summarized as follows:

 

 

Number of
Shares

 

 

Weighted
Average
Exercise
Price Per
Share

 

Options outstanding, January 31, 2026

 

 

1,260,295

 

 

$

199.72

 

Options granted

 

 

 

 

 

 

Options exercised (a)

 

 

(195,497

)

 

 

185.26

 

Options forfeited

 

 

(12,110

)

 

 

186.55

 

Options outstanding, August 1, 2026

 

 

1,052,688

 

 

 

202.56

 

(a)
Options exercised during the six month period ended August 1, 2026 had a total intrinsic value of $27.4 million.
Stock Options Vested and Expected to Vest as Well as Option Exercisable

The following table summarizes information about the stock options vested and expected to vest during the contractual term of such options as of August 1, 2026:

 

 

Options

 

 

Weighted
Average
Remaining
Contractual
Life (Years)

 

 

Weighted
Average
Exercise
Price

 

 

Aggregate
Intrinsic
Value
(in millions)

 

Options vested and expected to vest

 

 

1,052,688

 

 

 

5.7

 

 

$

202.56

 

 

$

174.7

 

Options exercisable

 

 

817,687

 

 

 

5.1

 

 

$

208.33

 

 

$

131.0

 

Award Grant and Vesting Transactions

Restricted stock unit transactions during the six month period ended August 1, 2026 are summarized as follows:

 

 

Number of
Shares

 

 

Weighted
Average Grant
Date Fair
Value Per
Award

 

Non-vested awards outstanding, January 31, 2026

 

 

727,513

 

 

$

207.18

 

Awards granted

 

 

273,944

 

 

 

317.71

 

Awards vested (a)

 

 

(256,242

)

 

 

200.52

 

Awards forfeited

 

 

(28,049

)

 

 

236.19

 

Non-vested awards outstanding, August 1, 2026

 

 

717,166

 

 

 

250.64

 

(a)
Restricted stock units vested during the six month period ended August 1, 2026 had a total intrinsic value of $81.3 million.
Performance Stock Unit Transactions

Performance stock unit transactions during the six month period ended August 1, 2026 are summarized as follows:

 

 

 

Number of
Shares

 

 

Weighted
Average Grant
Date Fair
Value Per
Award

 

Non-vested awards outstanding, January 31, 2026

 

 

363,954

 

 

$

200.92

 

Awards granted

 

 

213,530

 

 

 

255.46

 

Awards vested (a)

 

 

(195,656

)

 

 

184.94

 

Awards forfeited

 

 

(3,169

)

 

 

242.80

 

Non-vested awards outstanding, August 1, 2026

 

 

378,659

 

 

 

239.59

 

 

(a)
Performance-based stock awards vested during the six month period ended August 1, 2026 had a total intrinsic value of $62.3 million.